We want to change how biomarkers are routinely used in oncology

We use innovative diagnostic tools to determine the best therapeutic options for patients with cancer. We utilize pioneeringtechniques, sophisticated computer applications, and machine learning to reveal new cancer research data. We not only discover new biomarkers, we develop and implement them in the clinic as diagnostics tests.